BYD's Legal Headache in The Hague Collides With a Margin Warning From CLSA

BYD investors have two unrelated-looking problems landing in the same week, and both feed into the same question: whether volume growth can be converted into profit. On November 11, a preliminary hearing is scheduled in The Hague in the dispute with Jaguar Land Rover. Separately, CLSA cut its price target on the stock to 100 HK$ today while keeping its buy rating, warning that profit per exported vehicle could fall 20–30% next year.

The legal case traces back to suspicions reported by the Guardian that BYD reverse-engineered technology from the Defender for use in its Ti7 model. Court-appointed bailiffs seized documents at two Dutch BYD offices in August, according to that report. The allegations remain unresolved, and the hearing is a procedural step rather than a ruling.

What the Hearing Can and Cannot Settle

The central issue is how far the claim actually reaches. Jaguar Land Rover suspects, per the Guardian, that technology obtained through reverse engineering may have been used in the Ti7 — a qualification that matters, since the alleged deployment of the technology is itself part of the dispute. For anyone weighing the equity, the public sharpness of the conflict counts for less than its potential business impact. A limited scope would let sales and earnings power drive the valuation again; an adverse turn would carry more weight if it hampered BYD's operating recovery.

That recovery is already sending mixed signals. Net profit rose 28% year on year to 10.02 billion RMB in the third quarter of 2026, Reuters reported, but the figure fell short of analyst expectations. Revenue for the quarter climbed 13.6% to 221.49 billion RMB. Over the first nine months of 2026, however, net profit slipped 4.2% to 22.34 billion RMB — so the latest quarter's gain sits against a weaker longer stretch.

October Sales and the Export Bet

Volume tells a more encouraging story. BYD sold roughly 490,000 vehicles in October 2026, up 11% from a year earlier, with overseas deliveries jumping 102.8% to about 170,000 units. That cooling from September's 17% growth reflects soft domestic demand and fierce price competition at home, according to Reuters. Bloomberg, covering the earnings miss on October 30, pointed to a shrinking domestic car market and foreign efforts to curb Chinese imports as drags on Chinese auto stocks.

The export surge is the counterweight to the legal overhang — but only if the volumes come with adequate margins. CLSA's forecast of a 20–30% decline in profit per exported vehicle next year is precisely the caveat. Should that projection materialize, BYD would need to convince through additional unit sales abroad, and an unfavorable turn in the litigation could then weigh further on the valuation.

Product News Alongside the Headlines

On the operational front, BYD's Fang Cheng Bao sub-brand opened reservations today for the Tai 9 SUV without naming a price. The company also said it has produced its 19-millionth vehicle with an alternative drivetrain. The stock fell 4.0% today to €8.20, following a daily move of -3.8% in the prior session.

Two conditions would underpin the more optimistic case: the legal dispute stays manageable in business terms, and BYD can turn its sales opportunities profitable. That combination would be sturdier than pure volume growth and would shift attention back to operations without prejudging the court's outcome. If legal risks sharpen while export margins slide as CLSA expects, earnings would come under heavier pressure. The November 11 hearing provides the next checkpoint; the coming quarters must show how much of the growth actually reaches BYD's bottom line.